Home / Companies / Dr Reddy’s says German regulator makes 6 observations on its Duvvada unit

Dr Reddy’s says German regulator makes 6 observations on its Duvvada unit

Dr. Reddy’s did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports. Photo: Hindustan TimesPremium
Dr. Reddy’s did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports. Photo: Hindustan Times

Dr. Reddy's says a German regulator has made 6 major observations about its Duvvada drug making facility in Andhra Pradesh, sending shares down as much as 7.1%

Bengaluru/Mumbai: Dr. Reddy’s Laboratories said on Friday a German regulator has made six major observations about its Duvvada drug making facility in the southern Indian state of Andhra Pradesh, sending shares down as much as 7.1%.

Dr. Reddy’s, in an exchange filing, did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports.

A company spokeswoman did not immediately respond to a request for details of the observations on Friday.

The products manufactured at the unit are not currently exported to the European Union, it said.

Germany and the United Kingdom contribute the most to Dr. Reddy’s revenue from Europe, which rose 28% to Rs208 crore ($32.57 million) in the June quarter. Reuters

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout